KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Work In Process (2020 - 2023)

Historic Work In Process for Teladoc Health (TDOC) over the last 4 years, with Q1 2023 value amounting to $934000.0.

  • Teladoc Health's Work In Process rose 14643.8% to $934000.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $934000.0, marking a year-over-year increase of 14643.8%. This contributed to the annual value of $433000.0 for FY2022, which is 2747.07% down from last year.
  • According to the latest figures from Q1 2023, Teladoc Health's Work In Process is $934000.0, which was up 14643.8% from $433000.0 recorded in Q4 2022.
  • Teladoc Health's Work In Process' 5-year high stood at $1.4 million during Q4 2020, with a 5-year trough of $379000.0 in Q1 2022.
  • For the 4-year period, Teladoc Health's Work In Process averaged around $807400.0, with its median value being $736000.0 (2021).
  • In the last 5 years, Teladoc Health's Work In Process crashed by 6975.26% in 2022 and then soared by 14643.8% in 2023.
  • Quarter analysis of 4 years shows Teladoc Health's Work In Process stood at $1.4 million in 2020, then tumbled by 58.28% to $597000.0 in 2021, then fell by 27.47% to $433000.0 in 2022, then surged by 115.7% to $934000.0 in 2023.
  • Its last three reported values are $934000.0 in Q1 2023, $433000.0 for Q4 2022, and $1.2 million during Q3 2022.